Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 25Myelodysplastic Syndromes 8Advanced Solid Tumors 8Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Chronic 5Ovarian Neoplasms 4Neoplasms 4Multiple Myeloma 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Advanced Solid Tumor 4Small Cell Lung Carcinoma 3Recurrence 3Leukemia, Monocytic, Acute 3Triple Negative Breast Neoplasms 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Acute 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Biliary Tract Neoplasms 2Advanced Malignant Solid Tumor 2Advanced Lung Cancer 2

Interventions

tislelizumab 3toripalimab 1tazemetostat 1sintilimab 1pembrolizumab 1osimertinib 1enzalutamide 1envafolimab 1WW Domain-Containing Oxidoreductase 1Ultrasonography, Doppler 1Ultrasonography 1Specimen Handling 1Radiotherapy 1Oxaliplatin 1Off-Label Use 1Leucovorin 1Injections 1Indocyanine Green 1Immune Checkpoint Inhibitors 1Histocompatibility Testing 1Fluorouracil 1Fluorodeoxyglucose F18 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × Injections × 90 days × Clear all
NCT06132828 2026-04-27

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Zhejiang Doer Biologics Co., Ltd.

Phase 1 Recruiting
216 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡